TIDMCLL
RNS Number : 9465C
Cello Health PLC
20 June 2019
20 June 2019
Cello Health plc
("Cello" or the "Group")
Director/PDMR Shareholding
The Group announces that, on 20 June 2019, certain directors and
persons discharging managerial responsibilities (PDMRs) of the
Group exercised 10p options over a total of 965,000 ordinary shares
of 10 pence each ("Ordinary Shares") pursuant to the Group's PSP
Option Scheme 2010, and subsequently sold 600,100 Ordinary Shares
at a price of 126.6 pence per Ordinary Share. Details of the option
exercises, share sales and resultant shareholdings are set out
below:
Name Title Options Ordinary Resultant Percentage
exercised Shares holding of issued
sold share capital
Mark Scott Chief Executive 450,000 265,500 1,649,975 1.5%
Mark Bentley Finance Director 220,000 129,800 532,718 0.5%
Stephen Highley COO 220,000 129,800 2,226,304 2.1%
Deputy Finance
Andy Brown Director 75,000 75,000 6,160 0.01%
The new Ordinary Shares have been issued pursuant to the Group's
existing block listing and, as at 20 June 2019, Cello's issued
share capital comprises 106,530,309 Ordinary Shares, of which
453,000 Ordinary Shares are held in treasury. The Group's total
number of voting rights is therefore 106,077,309 Ordinary Shares,
which may be used by shareholders as the denominator for the
calculation by which they will determine if they are required to
notify their interest in, or a change in their interest in, the
Group under the FCA's Disclosure Guidance and Transparency
Rules.
This announcement contains inside information.
Enquiries:
Cello Health plc 020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Finance Director
Cenkos Securities plc 0207 397 8900
Mark Connelly
Harry Hargreaves
Notes to Editors
Cello Health plc is a global healthcare-focused advisory Group
comprised of a set of leading clinical, commercial advisory and
digital delivery capabilities. Cello Health plc currently services
24 of the top 25 pharmaceutical clients globally, as well as a wide
range of biotech, diagnostics, devices and other key non-healthcare
clients.
Cello Health plc enables clients to commercialise and
differentiate their assets and drive brand success in ever more
complex global markets. The business delivers its services through
nearly 1,000 highly skilled professionals, utilising latest
thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in
the UK, USA, and Asia, with hub offices in New York City,
Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit:
https://cellohealthplc.com
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mark Scott
--------------------------------------- -----------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status Chief Executive
--------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Cello Health plc
--------------------------------------- -----------------------------------------
b) LEI 2138004TZYGZLWQP7N64
--------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of the Options over ordinary shares of 10
financial instrument, pence each
type of instrument
Identification code ISIN: GB00B0310763
--------------------------------------- -----------------------------------------
b) Nature of the transaction Exercise of options
--------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------ ------------------
Price(s) Volume(s)
------------------ ------------------
10 pence 450,000
--------------------------------------------------------------- ------------------
d) Aggregated information
- Aggregated volume 450,000
- Price GBP45,000.00
--------------------------------------- ----------------------------------------------
e) Date of the transaction 20 June 2019
--------------------------------------- -----------------------------------------
f) Place of the transaction Outside of a trading venue (XOFF)
--------------------------------------- -----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mark Scott
------------------------------------- ---------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------
a) Position/status Chief Executive
------------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Cello Health plc
------------------------------------- ---------------------------------------
b) LEI 2138004TZYGZLWQP7N64
------------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument,
type of instrument
Identification code ISIN: GB00B0310763
------------------------------------- ---------------------------------------
b) Nature of the transaction Sale of ordinary shares
------------------------------------- ---------------------------------------
c) Price(s) and volume(s)
-------------------- --------------
Price(s) Volume(s)
-------------------- --------------
126.6 pence 265,000
--------------------------------------------------------------- --------------
d) Aggregated information
- Aggregated volume 265,000
- Price GBP336,123.00
------------------------------------- --------------------------------------------
e) Date of the transaction 20 June 2019
------------------------------------- ---------------------------------------
f) Place of the transaction AIMX
------------------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mark Bentley
--------------------------------------- -----------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status Finance Director
--------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Cello Health plc
--------------------------------------- -----------------------------------------
b) LEI 2138004TZYGZLWQP7N64
--------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of the Options over ordinary shares of 10
financial instrument, pence each
type of instrument
Identification code ISIN: GB00B0310763
--------------------------------------- -----------------------------------------
b) Nature of the transaction Exercise of options
--------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------ ------------------
Price(s) Volume(s)
------------------ ------------------
10 pence 220,000
--------------------------------------------------------------- ------------------
d) Aggregated information
- Aggregated volume 220,000
- Price GBP22,000.00
--------------------------------------- ----------------------------------------------
e) Date of the transaction 20 June 2019
--------------------------------------- -----------------------------------------
f) Place of the transaction Outside of a trading venue (XOFF)
--------------------------------------- -----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mark Bentley
------------------------------------- ---------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------
a) Position/status Finance Director
------------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Cello Health plc
------------------------------------- ---------------------------------------
b) LEI 2138004TZYGZLWQP7N64
------------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument,
type of instrument
Identification code ISIN: GB00B0310763
------------------------------------- ---------------------------------------
b) Nature of the transaction Sale of ordinary shares
------------------------------------- ---------------------------------------
c) Price(s) and volume(s)
-------------------- --------------
Price(s) Volume(s)
-------------------- --------------
126.6 pence 129,800
--------------------------------------------------------------- --------------
d) Aggregated information
- Aggregated volume 129,800
- Price GBP164,326.80
------------------------------------- --------------------------------------------
e) Date of the transaction 20 June 2019
------------------------------------- ---------------------------------------
f) Place of the transaction AIMX
------------------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Stephen Highley
--------------------------------------- -----------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status COO
--------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Cello Health plc
--------------------------------------- -----------------------------------------
b) LEI 2138004TZYGZLWQP7N64
--------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of the Options over ordinary shares of 10
financial instrument, pence each
type of instrument
Identification code ISIN: GB00B0310763
--------------------------------------- -----------------------------------------
b) Nature of the transaction Exercise of options
--------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------ ------------------
Price(s) Volume(s)
------------------ ------------------
10 pence 220,000
--------------------------------------------------------------- ------------------
d) Aggregated information
- Aggregated volume 220,000
- Price GBP22,000.00
--------------------------------------- ----------------------------------------------
e) Date of the transaction 20 June 2019
--------------------------------------- -----------------------------------------
f) Place of the transaction Outside of a trading venue (XOFF)
--------------------------------------- -----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Stephen Highley
------------------------------------- ---------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------
a) Position/status COO
------------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Cello Health plc
------------------------------------- ---------------------------------------
b) LEI 2138004TZYGZLWQP7N64
------------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument,
type of instrument
Identification code ISIN: GB00B0310763
------------------------------------- ---------------------------------------
b) Nature of the transaction Sale of ordinary shares
------------------------------------- ---------------------------------------
c) Price(s) and volume(s)
-------------------- --------------
Price(s) Volume(s)
-------------------- --------------
126.6 pence 129,800
--------------------------------------------------------------- --------------
d) Aggregated information
- Aggregated volume 129,800
- Price GBP164,326.80
------------------------------------- --------------------------------------------
e) Date of the transaction 20 June 2019
------------------------------------- ---------------------------------------
f) Place of the transaction AIMX
------------------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Andy Brown
--------------------------------------- -----------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status Deputy Finance Director
--------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Cello Health plc
--------------------------------------- -----------------------------------------
b) LEI 2138004TZYGZLWQP7N64
--------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of the Options over ordinary shares of 10
financial instrument, pence each
type of instrument
Identification code ISIN: GB00B0310763
--------------------------------------- -----------------------------------------
b) Nature of the transaction Exercise of options
--------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------ ------------------
Price(s) Volume(s)
------------------ ------------------
10 pence 75,000
--------------------------------------------------------------- ------------------
d) Aggregated information
- Aggregated volume 75,000
- Price GBP7,500.00
--------------------------------------- ----------------------------------------------
e) Date of the transaction 20 June 2019
--------------------------------------- -----------------------------------------
f) Place of the transaction Outside of a trading venue (XOFF)
--------------------------------------- -----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Andy Brown
------------------------------------- ---------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------
a) Position/status Group FC and CFO
------------------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Cello Health plc
------------------------------------- ---------------------------------------
b) LEI 2138004TZYGZLWQP7N64
------------------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument,
type of instrument
Identification code ISIN: GB00B0310763
------------------------------------- ---------------------------------------
b) Nature of the transaction Sale of ordinary shares
------------------------------------- ---------------------------------------
c) Price(s) and volume(s)
-------------------- --------------
Price(s) Volume(s)
-------------------- --------------
126.6 pence 75,000
--------------------------------------------------------------- --------------
d) Aggregated information
- Aggregated volume 75,000
- Price GBP94,950.00
------------------------------------- --------------------------------------------
e) Date of the transaction 20 June 2019
------------------------------------- ---------------------------------------
f) Place of the transaction AIMX
------------------------------------- ---------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHCKKDBPBKDFAB
(END) Dow Jones Newswires
June 20, 2019 11:29 ET (15:29 GMT)
Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024